Alexis A. Thompson, MD, MPH

home / authors / alexis-a-thompson-md-mph

Articles

Alexis A. Thompson, MD, MPH, Considers Future Assessments of Beti-Cel in β-Thalassemia

Alexis A. Thompson, MD, MPH, Considers Future Assessments of Beti-Cel in β-Thalassemia

Alexis A. Thompson, MD, MPH
August 26th 2022

Alexis A. Thompson, MD, MPH, reviewed the unmet needs of patients with β-thalassemia who will receive betibeglogene autotemcel.

Alexis A. Thompson, MD, MPH, Assesses the Need for Beti-Cel in β-Thalassemia

Alexis A. Thompson, MD, MPH, Assesses the Need for Beti-Cel in β-Thalassemia

Alexis A. Thompson, MD, MPH
August 20th 2022

Alexis A. Thompson, MD, MPH, reviewed unmet needs for patients with β-thalassemia who may now receive betibeglogene autotemcel.

Alexis A. Thompson, MD, MPH, Reviews Approval of Beti-Cel for β-Thalassemia

Alexis A. Thompson, MD, MPH, Reviews Approval of Beti-Cel for β-Thalassemia

Alexis A. Thompson, MD, MPH
August 17th 2022

Alexis A. Thompson, MD, MPH, spoke about the use of betibeglogene autotemcel for patients with β-thalassemia.

Latest Updated Articles

NSABP B-42 trial results show that the assay was predictive of extended letrozole therapy response, identifying a patient subset with improved outcomes.
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Data from the CheckMate-67T trial support the biologics license application for subcutaneous nivolumab in multiple solid tumors.
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
CT Abnormality in Patient With Stage II Breast Cancer History
Published: September 8th 2017 | Updated: November 23rd 2024
CT Abnormality in Patient With Stage II Breast Cancer History
A 46-Year-Old Woman Presents With Difficulty in Ambulation, and Swelling and Discoloration of Both Eyelids
Published: January 10th 2012 | Updated: November 23rd 2024
A 46-Year-Old Woman Presents With Difficulty in Ambulation, and Swelling and Discoloration of Both Eyelids
Breast Induration in 42-Year-Old Patient
Published: April 12th 2016 | Updated: November 23rd 2024
Breast Induration in 42-Year-Old Patient